Scribd Logo
Upload

Welcome to Scribd!

  • 24 views

    Accelerate Diagnostics, Inc.: Price, Consensus & Surprise

    Uploaded by

    derek_2010
    Accelerate Diagnostics, Inc. is a medical instruments company focused on developing rapid diagnostic platforms for identifying infectious pathogens and testing antibiotic susceptibility. Some key details: - The company is developing the BACcel system for rapid diagnosis of bacterial infections and OptiChem surface coatings. - It has a market capitalization of $1.38 billion and is ranked 20 out of 77 peers in the medical instruments industry. - Analysts project its sales will grow over 4,500% in the next fiscal year, however it has negative profit margins and return on equity.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content

    You might also like

    Accelerate Diagnostics, Inc.: Price, Consensus & Surprise

    Uploaded by

    derek_2010
    24 views1 page
    Accelerate Diagnostics, Inc. is a medical instruments company focused on developing rapid diagnostic platforms for identifying infectious pathogens and testing antibiotic susceptibility. Some key details: - The company is developing the BACcel system for rapid diagnosis of bacterial infections and OptiChem surface coatings. - It has a market capitalization of $1.38 billion and is ranked 20 out of 77 peers in the medical instruments industry. - Analysts project its sales will grow over 4,500% in the next fiscal year, however it has negative profit margins and return on equity.

    Original Description:

    RPT

    Original Title

    AXDX

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Accelerate Diagnostics, Inc. is a medical instruments company focused on developing rapid diagnostic platforms for identifying infectious pathogens and testing antibiotic susceptibility. Some key details: - The company is developing the BACcel system for rapid diagnosis of bacterial infections and OptiChem surface coatings. - It has a market capitalization of $1.38 billion and is ranked 20 out of 77 peers in the medical instruments industry. - Analysts project its sales will grow over 4,500% in the next fiscal year, however it has negative profit margins and return on equity.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    24 views1 page

    Accelerate Diagnostics, Inc.: Price, Consensus & Surprise

    Uploaded by

    derek_2010
    Accelerate Diagnostics, Inc. is a medical instruments company focused on developing rapid diagnostic platforms for identifying infectious pathogens and testing antibiotic susceptibility. Some key details: - The company is developing the BACcel system for rapid diagnosis of bacterial infections and OptiChem surface coatings. - It has a market capitalization of $1.38 billion and is ranked 20 out of 77 peers in the medical instruments industry. - Analysts project its sales will grow over 4,500% in the next fiscal year, however it has negative profit margins and return on equity.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    of 1

    August 05, 2017

    Accelerate Diagnostics, Inc. (NASD:AXDX) Zacks Rank: 3-Hold


    $25.15 USD (As of 08/04/2017) Style : Value: Growth: Momentum: VGM:

    52 Week High-Low $30.45 - $19.20 Price, Consensus & Surprise


    20 Day Average
    225,163
    Volume
    Beta 1.95

    Market Cap 1.38 B


    Dividend / Div Yld $0.00 / 0.00%
    Industry Medical - Instru..

    113 / 265 (Top


    Industry Rank
    43%)
    Proj. EPS Growth (Q1) 13.24%

    Proj. EPS Growth (F1) 8.27%


    P/E (F1) NA
    Last EPS Surprise -3.33%

    Avg. Last 4 Surprises 1.37%


    Next Report Date 11/8/2017

    Earnings ESP 0.00%

    Agreement Estimate Revisions (60 Days) Magnitude Consensus Estimate Trend (60 Days)

    Q1 Q2 F1 F2 Q1 Q2 F1 F2

    # of Analysts 2 2 3 3 Current -0.30 -0.29 -1.18 -0.90


    # of Revisions 0 0 0 0 7 Days Ago -0.30 -0.29 -1.18 -0.90

    # Up 0 0 0 0 30 Days Ago -0.30 -0.29 -1.18 -0.90

    # Down 0 0 0 0 60 Days Ago -0.30 -0.29 -1.18 -0.90

    Trend of
    % Revision Agreement:
    Estimate
    Revisions: 0% 0% 0% 0%

    Industry Comparison Medical - Instru.. | Position in Industry: 20 of 77 Industry Peers


    AXDX X Industry S&P 500 LENS ETRM CHFS

    Hist. EPS Growth (3-5 yrs) NA 14.15% 7.16% NA NA NA


    Proj. Sales Growth (F1/F0) 4,517.88% 7.80% 5.19% 1,601.70% -23.76% 0.00%
    Net Margin -5,062.48% -22.94% 9.92% NA -3,088.74% NA
    Return on Equity -80.75% -31.07% 15.95% -132.09% -506.36% -409.91%
    Debt/Capital NA 5.48% 41.54% 2.62% 0.00% 0.00%
    P/E (F1) NA 27.94 18.89 NA NA NA
    Price/Sales (P/S) 1,146.76 3.34 2.50 965.39 36.87 NA
    Price/Book (P/B) 19.93 3.21 3.22 3.04 1.55 0.93
    Price/Cash Flow (P/CF) NA 16.36 13.54 NA NA NA
    YTD % Price Change 27.71% 1.22% 9.77% -24.29% 101.50% -92.77%

    Description Medical > Medical Products > Medical - Instruments


    Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic
    susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in
    life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc.,
    formerly known as Accelr8 Technology Corp., is based in Denver, Colorado.

    Learn More about Zacks Rank and Style Scores

    You might also like